TURNOVER (x1000 NOK)
NET PROFIT (x1000 NOK)
EMPLOYEES
Xellia Pharmaceuticals AS
Closing information (x1000 NOK)
Closing information | 2019/12 | 2018/12 | 2017/12 |
Turnover | 76,651 | 78,619 | 83,514 |
Financial expenses | 19 | 34 | 8,720 |
Earnings before taxes | 25,319 | 28,123 | 7,439 |
Total assets | 600,322 | 575,419 | 550,384 |
Current assets | 149,800 | 123,564 | 104,021 |
Current liabilities | 21,191 | 20,703 | 22,176 |
Equity capital | 573,002 | 547,529 | 520,153 |
- share capital | 223,257 | 223,257 | 223,257 |
Employees (average) | 43 | ||
Shareholders | 0 | 0 | 0 |
Financial ratios
Fiscal year | 2019/12 | 2018/12 | 2017/12 |
Solvency | 95.4% | 95.2% | 94.5% |
Turnover per employee | 1,942 | ||
Profit as a percentage of turnover | 33.0% | 35.8% | 8.9% |
Return on assets (ROA) | 4.2% | 4.9% | 2.9% |
Current ratio | 706.9% | 596.8% | 469.1% |
Return on equity (ROE) | 4.4% | 5.1% | 1.4% |
Change turnover | -1,968 | -4,895 | -861 |
Change turnover % | -3% | -6% | -1% |
Chg. No. of employees | -4 | ||
Chg. No. of employees % | -9% |
Total value of public sale
Fiscal year | 2019/12 | 2018/12 | 2017/12 |
Total value of public sale | 0 | 0 | 0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.